I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 25% ± 6% | |
| fibroblast | 8 studies | 24% ± 6% | |
| epithelial cell | 7 studies | 29% ± 9% | |
| astrocyte | 6 studies | 30% ± 12% | |
| oligodendrocyte | 5 studies | 29% ± 7% | |
| neuron | 4 studies | 25% ± 10% | |
| plasma cell | 4 studies | 29% ± 10% | |
| adipocyte | 4 studies | 31% ± 6% | |
| ciliated cell | 4 studies | 23% ± 5% | |
| basal cell | 4 studies | 27% ± 12% | |
| abnormal cell | 4 studies | 29% ± 9% | |
| goblet cell | 4 studies | 28% ± 13% | |
| glutamatergic neuron | 4 studies | 44% ± 26% | |
| interneuron | 4 studies | 41% ± 22% | |
| GABAergic neuron | 4 studies | 39% ± 23% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 6% | |
| lymphocyte | 3 studies | 20% ± 3% | |
| muscle cell | 3 studies | 21% ± 5% | |
| B cell | 3 studies | 19% ± 3% | |
| dendritic cell | 3 studies | 22% ± 4% | |
| connective tissue cell | 3 studies | 24% ± 8% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 33% ± 9% | |
| pericyte | 3 studies | 24% ± 7% | |
| erythrocyte | 3 studies | 31% ± 12% | |
| transit amplifying cell | 3 studies | 38% ± 16% | |
| erythroblast | 3 studies | 30% ± 10% | |
| microglial cell | 3 studies | 24% ± 6% | |
| oligodendrocyte precursor cell | 3 studies | 37% ± 10% |
